Literature DB >> 15708923

Preliminary identification of core domains for outcome studies in psoriatic arthritis using Delphi methods.

W J Taylor1.   

Abstract

OBJECTIVE: To develop a consensus based set of core domains for outcome studies in psoriatic arthritis.
METHODS: A list of 26 potential domains was prepared through literature review and email discussions amongst the GRAPPA steering committee members and scored by rheumatologists identified through membership of the CASPAR study and the steering committee. Each participant was emailed an up to date review of outcome measures in psoriatic arthritis and asked to distribute 100 points amongst each potential domain. In two subsequent rounds the group median, interquartile range, and earlier responses were emailed to each respondent to provide an opportunity to revise their scoring.
RESULTS: Thirty two participants responded to the first round, of whom 30 responded to the third round. For DC-ART, the highest scoring domains were actively inflamed joint count, radiological damage score, patient global assessment, pain, physical function, acute phase response, and quality of life (scores 7 to 12). For SMARD, the highest scoring domains were pain, patient global assessment, physical function, quality of life, and active joint count (scores 10 to 18). For clinical record keeping, three domains scored highly at 10 (pain, patient global assessment, and active joint count). For rehabilitation, the highest scoring domains were physical function, quality of life, pain, patient global assessment, work limitations, and work incapacity (scores 10 to 15).
CONCLUSION: Amongst rheumatologists with an interest in psoriatic arthritis, a reduced list of potential standard outcome domains have been defined by Delphi consensus methods.

Entities:  

Mesh:

Year:  2005        PMID: 15708923      PMCID: PMC1766881          DOI: 10.1136/ard.2004.030874

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  6 in total

Review 1.  Epidemiology of psoriatic arthritis.

Authors:  William J Taylor
Journal:  Curr Opin Rheumatol       Date:  2002-03       Impact factor: 5.006

Review 2.  Assessment of patients with psoriatic arthritis: a review of currently available measures.

Authors:  Dafna D Gladman; Philip Helliwell; Philip J Mease; Peter Nash; Christopher Ritchlin; William Taylor
Journal:  Arthritis Rheum       Date:  2004-01

Review 3.  Consensus methods for medical and health services research.

Authors:  J Jones; D Hunter
Journal:  BMJ       Date:  1995-08-05

Review 4.  Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III.

Authors:  N Bellamy; J Kirwan; M Boers; P Brooks; V Strand; P Tugwell; R Altman; K Brandt; M Dougados; M Lequesne
Journal:  J Rheumatol       Date:  1997-04       Impact factor: 4.666

5.  Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group.

Authors:  D van der Heijde; N Bellamy; A Calin; M Dougados; M A Khan; S van der Linden
Journal:  J Rheumatol       Date:  1997-11       Impact factor: 4.666

Review 6.  Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. OMERACT Committee.

Authors:  P Tugwell; M Boers
Journal:  J Rheumatol       Date:  1993-03       Impact factor: 4.666

  6 in total
  8 in total

Review 1.  OMERACT 7 psoriatic arthritis workshop: synopsis.

Authors:  D D Gladman; V Strand; P J Mease; C Antoni; P Nash; A Kavanaugh
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

Review 2.  [Outcome parameters for use in psoriatic arthritis].

Authors:  J Braun; S Wassenberg
Journal:  Z Rheumatol       Date:  2006-03       Impact factor: 1.372

Review 3.  Consensus exercise on domains in psoriatic arthritis.

Authors:  D D Gladman
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

Review 4.  Outcome selection for tissue-agnostic drug trials for immune-mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance.

Authors:  Olalekan Lee Aiyegbusi; Lavinia Ferrante di Ruffano; Ameeta Retzer; Philip N Newsome; Christopher D Buckley; Melanie J Calvert
Journal:  Trials       Date:  2022-01-15       Impact factor: 2.279

5.  A delphi procedure on rehabilitation outcome for patients with moderate to severe traumatic brain injury; first phase of the Neurotraumatology Quality Registry (NET-QURE).

Authors:  Lianne D Peppel; Majanka H Heijenbrok-Kal; Thomas A Van Essen; Godard C W De Ruiter; Wilco C Peul; Gerard M Ribbers
Journal:  J Rehabil Med       Date:  2022-01-11       Impact factor: 2.912

Review 6.  Sex-Based Medicine Meets Psoriatic Arthritis: Lessons Learned and to Learn.

Authors:  Nicola Luigi Bragazzi; Charlie Bridgewood; Abdulla Watad; Giovanni Damiani; Dennis McGonagle
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

Review 7.  Patient involvement in outcome measures for psoriatic arthritis.

Authors:  William Tillett; Ade Adebajo; Mel Brooke; Willemina Campbell; Laura C Coates; Oliver FitzGerald; Laure Gossec; Philip Helliwell; Sarah Hewlett; Jana James; Patricia Minnock; Aisling Reast; Dennis O'Sullivan; Maarten de Wit; Neil McHugh
Journal:  Curr Rheumatol Rep       Date:  2014-05       Impact factor: 4.592

8.  Validation and application of a core set of patient-relevant outcome domains to assess the effectiveness of multimodal pain therapy (VAPAIN): a study protocol.

Authors:  Ulrike Kaiser; Christian Kopkow; Stefanie Deckert; Rainer Sabatowski; Jochen Schmitt
Journal:  BMJ Open       Date:  2015-11-06       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.